The CellSearch^® Circulating Tumor Cell (CTC) Test from Veridex is a simple blood test that captures and assesses CTCs to determine the prognosis of patients with metastatic breast, colorectal or prostate cancer at any time. The test can help you monitor your patients at baseline and each follow-up visit throughout their journey.

For patients undergoing Sentinel Lymph Node Testing, the GeneSearch™ Breast Lymph Node Assay is the first molecular test approved for the rapid detection of metastases greater than 0.2 mm in sentinel lymph node tissue offering the chance for fewer second surgeries and hospital stays.